Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review
- 19 September 2014
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 78 (4), 684-698
- https://doi.org/10.1111/bcp.12339
Abstract
While suboptimal adherence to statin medication has been quantified in real-world patient settings, a better understanding of its impact is needed, particularly with respect to distinct problems of medication taking. Our aim was to synthesize current evidence on the impacts of statin adherence, discontinuation and persistence on cardiovascular disease and mortality outcomes. We conducted a systematic review of peer-reviewed studies using a mapped search of Medline, Embase and International Pharmaceutical Abstracts databases. Observational studies that met the following criteria were included: defined patient population;statin adherence exposure; defined study outcome [i.e. cardiovascular disease (CVD), mortality]; and reporting of statin-specific results. Overall, 28 studies were included, with 19 studies evaluating outcomes associated with statin adherence, six with statin discontinuation and three with statin persistence. Among adherence studies, the proportion of days covered was the most widely used measure, with the majority of studies reporting increased risk of CVD (statistically significant risk estimates ranging from 1.22 to 5.26)and mortality (statistically significant risk estimates ranging from 1.25 to 2.54) among non-adherent individuals. There was greater methodological variability in discontinuation and persistence studies. However, findings of increased CVD (statistically significant risk estimates ranging from 1.22 to 1.67) and mortality (statistically significant risk estimates ranging from 1.79 to 5.00) among nonpersistent individuals were also consistently reported. Observational studies consistently report an increased risk of adverse outcomes associated with poor statin adherence. These findings have important implications for patients and physicians and emphasize the importance of monitoring and encouraging adherence to statin therapy.Keywords
This publication has 49 references indexed in Scilit:
- Adherence to statins is associated with reduced incidence of idiopathic venous thromboembolism: real-life data from a large healthcare maintenance organisationHeart, 2012
- Statin usage and all‐cause and disease‐specific mortality in a nationwide studyPharmacoepidemiology and Drug Safety, 2011
- Long-term persistence with statin treatment in a not-for-profit health maintenance organization: A population-based retrospective cohort study in IsraelClinical Therapeutics, 2008
- Impact of adherence to statins on chronic heart failure in primary preventionBritish Journal of Clinical Pharmacology, 2008
- Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10‐year follow‐up of outcomeBritish Journal of Clinical Pharmacology, 2008
- Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery diseaseAmerican Heart Journal, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Impact of adherence to statins on coronary artery disease in primary preventionBritish Journal of Clinical Pharmacology, 2007
- Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysisHeart, 2005
- Adherence to MedicationNew England Journal of Medicine, 2005